We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Analytical Validation of a DNA Methylation Biomarker Test for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma from Samples Collected Using EsoCheck ® , a Non-Endoscopic Esophageal Cell Collection Device.
- Authors
Ghosal, Abhisek; Verma, Suman; Le, Ivy T.; Lee, Victoria T.; deGuzman, Brian J.; Aklog, Lishan
- Abstract
Barrett's esophagus (BE) is a known precursor to esophageal adenocarcinoma (EAC). Guidelines recommend BE screening in populations with multiple risk factors, for which non-endoscopic esophageal cell collection with biomarker testing is considered as an acceptable alternative to esophagogastroduodenoscopy (EGD). The aim of this study was to evaluate analytical performance characteristics of EsoGuard® (EG), a DNA methylation biomarker assay, as a laboratory-developed test (LDT) in esophageal samples collected with the swallowable EsoCheck® (EC) device. EG is a next-generation sequencing (NGS) assay that evaluates methylated vimentin (VIM) and cyclin A1 (CCNA1), clinically validated biomarkers for the detection of BE and EAC. The studies were conducted according to standards of College of American Pathology (CAP), Clinical Laboratory Improvement Amendments (CLIA), and New York (NY) state requirements for the analytical validation of molecular assays. Comparison to Sanger sequencing showed that EG was 100% accurate at all 31 CpG sites evaluated by the assay. The analytical sensitivity, specificity, and accuracy of the assay were 89%, 100%, and 96%, respectively. Intra- and inter-assay precision was 100%. The limit of detection (LOD) was 1 in 400 methylated cells, and the reference range was 84%. In summary, EsoGuard demonstrates high analytical accuracy, repeatability, and reproducibility in samples collected using the EsoCheck device.
- Subjects
COLLEGE of American Pathologists; BARRETT'S esophagus; DNA methylation; NUCLEOTIDE sequencing; BIOMARKERS; DETECTION limit
- Publication
Diagnostics (2075-4418), 2024, Vol 14, Issue 16, p1784
- ISSN
2075-4418
- Publication type
Article
- DOI
10.3390/diagnostics14161784